These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 8637703

  • 21. Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.
    Kato M, Iwashita T, Takeda K, Akhand AA, Liu W, Yoshihara M, Asai N, Suzuki H, Takahashi M, Nakashima I.
    Mol Biol Cell; 2000 Jan; 11(1):93-101. PubMed ID: 10637293
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Absence of MEN2A- or 2B-type RET mutations in primary neuroblastoma tumour tissue.
    Peaston AE, Camacho ML, Norris MD, Haber M, Marsh DJ, Robinson BG, Hyland VJ, Marshall GM.
    Mol Cell Probes; 1998 Aug; 12(4):239-42. PubMed ID: 9727201
    [Abstract] [Full Text] [Related]

  • 25. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM, Lammers R, Arlt D, Höppner W, Strack V, Niederfellner G, Seif FJ, Häring HU, Kellerer M.
    Mol Cell Endocrinol; 2000 Sep 25; 167(1-2):69-76. PubMed ID: 11000521
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
    Takahashi M, Asai N, Iwashita T, Murakami H, Ito S.
    Recent Results Cancer Res; 1998 Sep 25; 154():229-36. PubMed ID: 10027003
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
    Engelmann D, Koczan D, Ricken P, Rimpler U, Pahnke J, Li Z, Pützer BM.
    Endocr Relat Cancer; 2009 Mar 25; 16(1):211-24. PubMed ID: 18984779
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.
    Pandit SD, Donis-Keller H, Iwamoto T, Tomich JM, Pike LJ.
    J Biol Chem; 1996 Mar 08; 271(10):5850-8. PubMed ID: 8621456
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
    Ponder BA.
    Cancer Surv; 1995 Mar 08; 25():195-205. PubMed ID: 8718519
    [No Abstract] [Full Text] [Related]

  • 39. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival.
    De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A, Billaud M, Fusco A, Tsichlis PN, Santoro M.
    Cancer Res; 2000 Jul 15; 60(14):3727-31. PubMed ID: 10919641
    [Abstract] [Full Text] [Related]

  • 40. Cell signalling and gene expression mediated by RET tyrosine kinase.
    Kurokawa K, Kawai K, Hashimoto M, Ito Y, Takahashi M.
    J Intern Med; 2003 Jun 15; 253(6):627-33. PubMed ID: 12755958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.